These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 6346844)
1. The effects of bromocriptine in patients with congestive heart failure. Francis GS; Parks R; Cohn JN Am Heart J; 1983 Jul; 106(1 Pt 1):100-6. PubMed ID: 6346844 [TBL] [Abstract][Full Text] [Related]
2. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril). Kluger J; Cody RJ; Laragh JH Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087 [TBL] [Abstract][Full Text] [Related]
3. Effects of bucindolol on neurohormonal activation in congestive heart failure. Eichhorn EJ; McGhie AL; Bedotto JB; Corbett JR; Malloy CR; Hatfield BA; Deitchman D; Willard JE; Grayburn PA Am J Cardiol; 1991 Jan; 67(1):67-73. PubMed ID: 1670902 [TBL] [Abstract][Full Text] [Related]
4. Neurohormonal activation and the response to converting enzyme inhibitors in congestive heart failure. Kubo SH Circulation; 1990 Feb; 81(2 Suppl):III107-14. PubMed ID: 2137052 [TBL] [Abstract][Full Text] [Related]
5. A clinical study on the role of the renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure. Nishioka A; Kubo S; Hirota Y; Kawamura K; Takatsu T Jpn Heart J; 1982 Jul; 23(4):527-44. PubMed ID: 6752473 [TBL] [Abstract][Full Text] [Related]
6. Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system. Creager MA; Faxon DP; Cutler SS; Kohlmann O; Ryan TJ; Gavras H J Am Coll Cardiol; 1986 Apr; 7(4):758-65. PubMed ID: 3514728 [TBL] [Abstract][Full Text] [Related]
7. Baroreceptor-mediated release of vasopressin in patients with chronic congestive heart failure and defective sympathetic responsiveness. Manthey J; Dietz R; Opherk D; Osterziel KJ; Leinberger H; Kübler W Am J Cardiol; 1992 Jul; 70(2):224-8. PubMed ID: 1626511 [TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of renin inhibition by enalkiren in chronic congestive heart failure. Neuberg GW; Kukin ML; Penn J; Medina N; Yushak M; Packer M Am J Cardiol; 1991 Jan; 67(1):63-6. PubMed ID: 1986506 [TBL] [Abstract][Full Text] [Related]
9. Hemodynamic, renal, and neurohumoral effects of a selective oral DA1 receptor agonist (fenoldopam) in patients with congestive heart failure. Francis GS; Wilson BC; Rector TS Am Heart J; 1988 Aug; 116(2 Pt 1):473-9. PubMed ID: 2899970 [TBL] [Abstract][Full Text] [Related]
10. Endogenous prostaglandin E2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodynamic response to captopril in chronic congestive heart failure. Silberbauer K; Punzengruber C; Sinzinger H Cardiology; 1983; 70(6):297-307. PubMed ID: 6370431 [TBL] [Abstract][Full Text] [Related]
11. [Hemodynamic and biological effects of bromocriptine in essential hypertension]. Allain H; Daubert JC; Massart C; van den Driessche J; Gouffault J Arch Mal Coeur Vaiss; 1982 Sep; 75(9):951-62. PubMed ID: 6816179 [TBL] [Abstract][Full Text] [Related]
12. Suppressing sympathetic activation in congestive heart failure. A new therapeutic strategy. Manolis AJ; Olympios C; Sifaki M; Handanis S; Bresnahan M; Gavras I; Gavras H Hypertension; 1995 Nov; 26(5):719-24. PubMed ID: 7591009 [TBL] [Abstract][Full Text] [Related]
13. Dissociation of the responses of the renin-angiotensin system and sympathetic nervous system to a vasodilator stimulus in congestive heart failure. Levine TB; Olivari MT; Cohn JN Int J Cardiol; 1986 Aug; 12(2):165-73. PubMed ID: 3744598 [TBL] [Abstract][Full Text] [Related]
14. Responses of plasma norepinephrine and renin-angiotensin-aldosterone system to dynamic exercise in patients with congestive heart failure. Kato M; Kinugawa T; Omodani H; Osaki S; Ahmmed GU; Ogino K; Hisatome I; Miyakoda H; Thames MD J Card Fail; 1996 Jun; 2(2):103-10. PubMed ID: 8798111 [TBL] [Abstract][Full Text] [Related]
15. Hemodynamic changes and renal plasma flow in early heart failure: implications for renin, aldosterone, norepinephrine, atrial natriuretic peptide and prostacyclin. Holmer SR; Riegger AJ; Notheis WF; Kromer EP; Kochsiek K Basic Res Cardiol; 1987; 82(2):101-8. PubMed ID: 2955780 [TBL] [Abstract][Full Text] [Related]
16. Hemodynamic and clinical response to enalapril, a long-acting converting-enzyme inhibitor, in patients with congestive heart failure. Levine TB; Olivari MT; Garberg V; Sharkey SW; Cohn JN Circulation; 1984 Mar; 69(3):548-53. PubMed ID: 6319045 [TBL] [Abstract][Full Text] [Related]
17. [Sympathetic activity in patients with heart failure due to idiopathic dilated cardiomyopathy: effect of ACE inhibitors and other vasodilators]. Langes K; Bleifeld W Herz; 1990 Jun; 15(3):164-70. PubMed ID: 2198217 [TBL] [Abstract][Full Text] [Related]
18. Enalapril in congestive heart failure: acute hemodynamic and neurohumoral evaluation and short-term follow-up. Lin M; Chiang HT; Chang MS; Kong CW; Wang SP; Chiang BN Zhonghua Yi Xue Za Zhi (Taipei); 1991 Jul; 48(1):31-40. PubMed ID: 1679372 [TBL] [Abstract][Full Text] [Related]
19. Clinical and hemodynamic improvement of congestive heart failure by long-term vasodilator therapy with postjunctional alpha 1-adrenoceptor blockade. Bertel O; Bühler FR; Burkart F J Cardiovasc Pharmacol; 1982; 4 Suppl 1():S181-6. PubMed ID: 6175837 [TBL] [Abstract][Full Text] [Related]
20. Enalapril: a new angiotensin-converting enzyme inhibitor in chronic heart failure: acute and chronic hemodynamic evaluations. DiCarlo L; Chatterjee K; Parmley WW; Swedberg K; Atherton B; Curran D; Cucci M J Am Coll Cardiol; 1983 Nov; 2(5):865-71. PubMed ID: 6313787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]